Magnesium L-Threonate: Benefits, Dosage and Human Research

Magnesium L-threonate is a magnesium salt studied for cognition, sleep and magnesium delivery. Its main appeal is a developing body of form-specific human research, supported by earlier animal work on brain magnesium and synaptic function.

The human findings are promising in selected settings, but the formulation and amount matter. A gram-level stand-alone L-threonate regimen, a multi-ingredient cognition formula and a small L-threonate addition in a D3/K2 capsule are different interventions.

What is magnesium L-threonate?

The compound combines magnesium with L-threonate. Its total mass includes both the magnesium and the accompanying chemical components. It is therefore not pure magnesium, and a label's compound-weight number is different from elemental magnesium.

Magtein is a branded L-threonate ingredient used in several studies. The ingredient name helps identify a formulation, but does not establish that every product containing it uses the same daily amount or has been tested for the same outcome.

L-threonate is also different from L-theanine and L-threonine. Similar spelling does not mean the substances share a dose, mechanism or evidence base.

Where the brain-magnesium idea came from

The foundational preclinical study examined learning, memory and synaptic function after raising brain magnesium in rats. It helped establish a reason to investigate L-threonate for cognitive outcomes.

Animal findings are valuable for understanding a mechanism. Direct human claims still need human evidence. A blood-magnesium change or cognitive-test improvement does not directly measure a person's brain-magnesium concentration, and animal dosing cannot be copied into a consumer regimen.

Human cognition trials compared

Read the MMFS-01 trial, MagteinPS trial and 2026 report as different studies, not three replications of one identical product.

How large were the cognitive effects?

The 2016 MMFS-01 study reported a composite-cognition effect size of Cohen's d = 0.91. That is a notable result within a small trial. Small samples, participant selection and formulation-specific methods can also make effects less stable than a headline suggests.

The 2026 trial found a difference in the NIH Total Cognition Composite, with larger signals in working and episodic memory. It did not show a difference on Raven's test. A positive result on one cognitive battery should therefore not be described as an improvement in every kind of intelligence or memory.

What does “7.5 years younger cognitive age” mean?

The 2026 study translated performance on a test into an estimated age-equivalent measure using normative data. It did not measure a brain physically becoming 7.5 years younger or establish a reversal of dementia pathology.

Age-equivalent scores can make a result easier to communicate, but they should stay attached to the underlying test and its exploratory interpretation. The clinical questions are whether function improves meaningfully and whether an effect persists over longer follow-up.

An October 2026 correction clarified two-tailed statistical testing without changing the reported results. That update belongs alongside the original paper.

Sleep and daytime-function evidence

A 2024 trial in 80 adults tested 1 g/day for 21 days and found selected improvements in wearable-derived scores and daytime functioning. The 2026 trial found improvement in sleep-related impairment, while objective wearable sleep measures and several subjective measures did not differ significantly.

These findings are more useful when the exact endpoint is named. Better waking function is different from a proven increase in total sleep time. The sleep review compares dose, timing, questionnaires, wearable measurements and corrections.

Anxiety, mood and other uses

Sleep, stress and mood often overlap in supplement marketing. The evidence does not establish L-threonate as a general treatment for an anxiety disorder or depression. Those conditions need their own clinical assessment and outcome evidence.

Specialist pain trials also exist. An advanced-cancer study examined L-threonate alongside opioid treatment, while a breast-surgery trial did not significantly prevent persistent postoperative pain. These settings cannot be turned into a general over-the-counter pain-relief claim.

How much was used in the studies?

Human cognition and sleep studies commonly use gram-level amounts of the compound or study formulation. In the 2026 trial, 2,000 mg supplied 145 mg elemental magnesium. The serving was split between morning and evening.

That is a study regimen, not a universal dose recommendation. The dosage guide includes the major trial amounts and explains compound/elemental calculations.

EFSA's safety assessment concerned a specified novel-food material under defined adult conditions of use. Its safety conclusion is separate from proof that a dose improves cognition or sleep.

How soon might a benefit be assessed?

The cited studies run from three weeks to three months. An immediate sensation after one capsule does not establish a cognitive benefit, while a preventive claim would require much longer evidence.

If a supplement is being evaluated for an appropriate purpose, define the outcome and timeframe beforehand. Avoid changing several products at once, and consider whether sleep, caffeine, stress or medicines are changing at the same time.

L-threonate versus glycinate

L-threonate has more form-specific cognition research. Glycinate also has sleep research, including a 2025 randomized study that reported a small improvement in insomnia severity.

These are indirect comparisons. They do not establish a universal winner or prove that the form with the stronger brain-delivery narrative produces better everyday results. Use the direct comparison guide for outcomes, elemental dose and cost.

Where a D3/K2/L-threonate capsule fits

DoNotAge combines L-threonate with D3 and MK-7 in one capsule. It is our first option for that combination when its D3 strength fits the intended plan. We have an affiliate relationship with the brand.

Its current 250 mg L-threonate compound amount serves a different formulation purpose from the gram-level stand-alone trials. Do not multiply the combination to match a magnesium study, because the D3 rises too. The buying guide explains the tradeoff.

Safety before experimentation

Review elemental intake, other magnesium products, kidney function and interacting medicines. Gastrointestinal symptoms can occur with magnesium supplements. Short studies cannot exclude uncommon or long-term adverse effects.

The safety guide covers the EFSA assessment, reported events and medication timing. Choosing L-threonate makes most sense when its evidence matches a defined goal and the product's actual dose is clear.

Research and sources

Explore the D3, K2 and magnesium research data center for study summaries, population and formulation details, limitations and original publication links. Source links throughout this guide point to the relevant evidence or official guidance.